Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio
Marketwire - Thu Apr 17, 10:30AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Skystar Bio-Pharmaceutical Up 42.5% Since SmarTrend Uptrend Call (SKBI)
Comtex SmarTrend(R) - Thu Apr 03, 9:37AM CDT
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 2 months, Skystar Bio-Pharmaceutical has returned 42.54% as of today's recent price of $6.50.
Skystar Bio-Pharmaceutical Reports Fiscal Year 2013 Financial Results and Meets Full Year Guidance
Marketwire - Mon Mar 31, 6:05PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Skystar to File Financial Results for Full Fiscal Year 2013 on Monday, March 31, 2014
Marketwire - Mon Mar 31, 8:04AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
4 Stocks Under to Trade for Breakouts
at The Street - Fri Mar 21, 5:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.
The Next Big Biotech Mover: Ariad Pharma
at The Street - Wed Mar 19, 1:00PM CDT
Ariad Pharmaceuticals could be the next biotech stock setting up for a monster move higher, according to Roberto Pedone.
Uptrend Call Working As Skystar Bio-Pharmaceutical Stock Rises 29.4% (SKBI)
Comtex SmarTrend(R) - Wed Mar 12, 11:01AM CDT
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 4 weeks, Skystar Bio-Pharmaceutical has returned 29.39% as of today's recent price of $5.90.
40.1% Return Seen to Date on SmarTrend Skystar Bio-Pharmaceutical Call (SKBI)
Comtex SmarTrend(R) - Wed Mar 05, 9:38AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 3 weeks, Skystar Bio-Pharmaceutical has returned 40.13% as of today's recent price of $6.39.
Shares of SKBI Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 26, 9:15AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 2 weeks, Skystar Bio-Pharmaceutical has returned 22.81% as of today's recent price of $5.60.
5 Stocks Ready to Explode Higher
at The Street - Wed Feb 12, 1:13PM CST
These stocks could be sett9ing up for explosive moves higher soon.
4 Biotech Stocks Under $10 Making Big Moves
at The Street - Wed Jan 29, 6:00AM CST
Keep these under-$10 biotech stocks on your radar.
Skystar Bio-Pharmaceutical posts increased net income of USD3.7m in Q3 2013
M2 - Mon Nov 18, 3:06AM CST
Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, on Friday reported unaudited net income of USD3.7m, or USD0.49 per fully diluted share, for the third quarter of fiscal year 2013, ended 30 September 2013.
Skystar Bio-Pharmaceutical Reports Third Quarter 2013 Results
Marketwire - Fri Nov 15, 4:00AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Skystar Bio-Pharmaceutical to Host Third Quarter 2013 Earnings Webcast Live on Friday, November 15, 2013
ACCESSWIRE - Thu Nov 14, 8:36AM CST
XI'AN, CHINA - (ACCESSWIRE - November 14, 2013) - Skystar Bio-Pharmaceutical Company (SKBI) will host a live webcast to discuss the results of the third quarter 2013, to be held Friday, November 15, 2013 at 7:45 a.m. Eastern Time.
Skystar to File Financial Results for Third Quarter of Fiscal 2013 on Thursday, November 14, 2013
Marketwire - Thu Nov 14, 8:30AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Skystar Bio-Pharmaceutical Reports Second Quarter 2013 Results
Marketwire - Wed Aug 14, 2:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Skystar to File Financial Results for Second Quarter of Fiscal 2013 on Wednesday, August 14, 2013
Marketwire - Tue Aug 13, 4:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"
Market Maker Surveillance Report. CIEN, CHTP, NLST, SKBI, MY, NPTN, Winning Stocks With Lowest Price Friction For Thursday, June 6th 2013
M2 - Fri Jun 07, 3:00AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3815 companies with "abnormal" market making, 3439 companies with positive Friction Factors and 1883 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Ciena Corp (NASDAQ:CIEN), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Netlist Inc (NASDAQ:NLST), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), China Ming Yang Wind Power Group Ltd (NYSE:MY), NeoPhotonics Corp (NYSE:NPTN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .